SCHEMBL1899591

SCHEMBL1899591

CCCCCCOC(C)(C)O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.45
THRB P10828 2/20 0.43
MEN1 O00255 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPT P10636 1/20 0.43
LPAR3 Q9UBY5 6/20 0.41
LPAR2 Q9HBW0 5/20 0.41
LPAR1 Q92633 2/20 0.41
NAAA Q02083 1/20 0.41
CES2 O00748 2/20 0.41
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
TSHR P16473 1/20 0.40
GBA1 P04062 1/20 0.40
EPHX1 P07099 1/20 0.39
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15308094 1.00 CES1 (0.45) CES1THRBMEN1HTTKMT2A
SCHEMBL13456958 1.00 CES1 (0.45) CES1THRBMEN1HTTKMT2A
Ammonia Solution, Strong SCHEMBL6230421 0.98 CES1 (0.44) CES1THRBMEN1HTTKMT2A
SCHEMBL2808705 0.97 CES1 (0.42) CES1THRBMEN1HTTKMT2A
SCHEMBL434225 0.90
SCHEMBL8769729 0.85 CES1 (0.45) CES1THRBMEN1HTTKMT2A
SCHEMBL20145201 0.85 CES1 (0.45) CES1THRBMEN1HTTKMT2A
SCHEMBL30634500 0.82 CES1 (0.47) CES1THRBMEN1HTTKMT2A
SCHEMBL4939579 0.81 LPAR3 (0.43) CES1THRBMEN1HTTKMT2A
SCHEMBL29219352 0.81 CES1 (0.42) CES1THRBMEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1989002599-A1 DETECTION OF SURVIVED, UNDEGRADED CARBOHYDRATE EPITOPES AS DIAGNOSTIC OF INTESTINAL DISEASES THE BIOMEMBRANE INSTITUTE (US) 1989-03-23 WO claimed
JP-2110102-A None JP disclosed
US-9777243-B2 Methods for obtaining corn oil from milled corn germ THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 2017-10-03 US disclosed
US-20160201006-A1 Methods for Obtaining Corn Oil from Milled Corn Germ DANISCO US INC. 2016-07-14 US disclosed
US-20160084855-A1 Compositions and Methods for Modulation and Detection of Immune and Inflammatory Responses UNIVERSITY OF CONNECTICUT (US) 2016-03-24 US disclosed
EP-2986988-A1 COMPOSITIONS AND METHODS FOR MODULATION AND DETECTION OF IMMUNE AND INFLAMMATORY RESPONSES University of Connecticut (US) 2016-02-24 EP disclosed
CN-105092719-A Method for measuring content of lysophospholipid in multivitamins for injection Chongqing yaoyou pharmaceutical co ltd 2015-11-25 CN disclosed
CN-104931618-A Multiple detection method for six phospholipid in complex sample LU HANG 2015-09-23 CN disclosed
EP-2324060-B1 ANTI-EXTENDED TYPE I GLYCOSPHINGOLIPID ANTIBODY, DERIVATIVES THEREOF AND USE GLYCONEX INC (TW) 2015-07-22 EP disclosed
WO-2014172633-A1 COMPOSITIONS AND METHODS FOR MODULATION AND DETECTION OF IMMUNE AND INFLAMMATORY RESPONSES UNIVERSITY OF CONNECTICUT (US) 2014-10-23 WO disclosed
JP-H02110102-A NOVEL LONG CHAIN GLYCOLIPID STRUCTURE BIOMEMBRANE INST 1990-04-23 JP disclosed
EP-0351045-A2 Monoclonal antibody NUH2 capable of inactivating motility of sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen The Biomembrane Institute (US) 1990-01-17 EP disclosed
EP-0344955-A2 Novel long-chain glycolipid structure The Biomembrane Institute (US) 1989-12-06 EP disclosed
EP-0332298-A2 Methods of preparing de-N-acylated and N-acylated glycospingo lipids and lyso forms of glycospingo lipids The Biomembrane Institute (US) 1989-09-13 EP disclosed
US-4851511-A GANGLIOSIDES, KITS, HYBRIDOMAS, CELLS FRED HUTCHINSON CANCER RESEARCH CENTER (US) 1989-07-25 US disclosed
WO-1989002599-A1 DETECTION OF SURVIVED, UNDEGRADED CARBOHYDRATE EPITOPES AS DIAGNOSTIC OF INTESTINAL DISEASES THE BIOMEMBRANE INSTITUTE (US) 1989-03-23 WO disclosed
EP-0263174-A4 INCREASED VASCULAR PERFUSION FOLLOWING ADMINISTRATION OF LIPIDS. ANGIO MEDICAL CORP (US) 1988-11-24 EP disclosed
US-4769362-A Increased vascular perfusion following administration of lipids TRUSTEES OF BOSTON UNIVERSITY (US) 1988-09-06 US disclosed
EP-0263174-A1 INCREASED VASCULAR PERFUSION FOLLOWING ADMINISTRATION OF LIPIDS Angio-Medical Corporation (US) 1988-04-13 EP disclosed
WO-1987006136-A1 INCREASED VASCULAR PERFUSION FOLLOWING ADMINISTRATION OF LIPIDS ANGIO-MEDICAL CORPORATION (US) 1987-10-22 WO disclosed